Silvergate Capital Q3 EPS $0.88 Beats $0.71 Estimate

Silvergate Capital (NYSE:SI) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.71 by 23.94 percent. This is a 137.84 percent increase over earnings of $0.37 per share from the

byBill Haddad

October 19, 2021

1 minute read

This Rare Disease Focused Stock Pipeline Is Underappreciated, Analyst Initiating Coverage Says

By Vandana Singh

November 17, 3:05 PM

Cantor Fitzgerald has initiated coverage on KemPharm Inc (NASDAQ:KMPH) with an Overweight rating and a price target of $20. Per the analyst,…

KMPH

News

Venator To Permanently Close TiO2 Production At Duisburg Site

By Benzinga Newsdesk

February 21, 7:07 AM

We are in the process of restarting production for both TiO2 and functional additives in the first quarter of 2023, however we do not believe it is economically viable to continue TiO2 production

VNTR

GT Biopharma Q2 EPS $(0.10) Up From $(0.15) YoY

By Benzinga Newsdesk

August 11, 9:36 AM

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.10) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year.

GTBP

Housing Beat: Mortgage Rates Keep Climbing; Disney’s Affordable Housing Project

By Phil Hall

April 7, 11:56 AM

Mortgage rates are continuing their upward motion while potential homebuyers and sellers face a shifting housing market and the affordable housing sector welcomes a well-known new participant.

DIS

Silvergate Capital Q3 EPS $0.88 Beats $0.71 Estimate

Related Posts

This Rare Disease Focused Stock Pipeline Is Underappreciated, Analyst Initiating Coverage Says

Venator To Permanently Close TiO2 Production At Duisburg Site

GT Biopharma Q2 EPS $(0.10) Up From $(0.15) YoY

Housing Beat: Mortgage Rates Keep Climbing; Disney’s Affordable Housing Project